Mustafa Munye

Mustafa has significant industry experience in the discovery and development of cell and gene therapies gained at GSK and CGTC. He has previously led process and analytical development for AAV, CAR-T, and PSC-derived cell therapy products to support FIH and late-stage clinical studies. Mustafa serves as a board member of the British Society for Gene and Cell Therapy working in pan-industry/academia working groups to overcome common barriers to the translation and commercialization of Advanced Therapies.